IFN-β併用多剤化学療法(DAC-Tam療法)が奏効した直腸肛門部悪性黒色腫の1例

紀子 川野, 充生 田代, 雅史 田口, 康之 木原, 一郎 芳川, 和孝 宿輪, 雅弘 山崎, 久米 恵一郎, 眞 大槻
{"title":"IFN-β併用多剤化学療法(DAC-Tam療法)が奏効した直腸肛門部悪性黒色腫の1例","authors":"紀子 川野, 充生 田代, 雅史 田口, 康之 木原, 一郎 芳川, 和孝 宿輪, 雅弘 山崎, 久米 恵一郎, 眞 大槻","doi":"10.11405/NISSHOSHI.105.1627","DOIUrl":null,"url":null,"abstract":": A 73-year-old man, who was diagnosed as having advanced anorectal malignant melanoma (Stage IV), was treated with combination chemotherapy using dacarbazine, nimustine, cisplatin, and tamoxifen plus interferon-beta. After the first course of chemotherapy, rectal tumor was decreased in size with less anal pain and liver tumor was disappeared. Twenty-four months after the first treatment, the patient is survived. DAC-Tam IFN-beta therapy may improve the management of patients who have advanced MM of the anorectum.","PeriodicalId":341053,"journal":{"name":"The Japanese journal of gastro-enterology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2008-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Japanese journal of gastro-enterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11405/NISSHOSHI.105.1627","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

: A 73-year-old man, who was diagnosed as having advanced anorectal malignant melanoma (Stage IV), was treated with combination chemotherapy using dacarbazine, nimustine, cisplatin, and tamoxifen plus interferon-beta. After the first course of chemotherapy, rectal tumor was decreased in size with less anal pain and liver tumor was disappeared. Twenty-four months after the first treatment, the patient is survived. DAC-Tam IFN-beta therapy may improve the management of patients who have advanced MM of the anorectum.
IFN-β联合多药化疗(DAC-Tam疗法)奏效的直肠肛门部恶性黑色素瘤1例
例73岁男性,诊断为晚期肛门直肠恶性黑色素瘤(IV期),采用达卡巴嗪、尼莫司汀、顺铂、他莫昔芬加干扰素联合化疗。第一疗程化疗后,直肠肿瘤体积减小,肛门疼痛减轻,肝脏肿瘤消失。第一次治疗24个月后,患者存活了下来。DAC-Tam ifn - β治疗可改善晚期肛肠MM患者的管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信